348 related articles for article (PubMed ID: 27487158)
1. New Initiation of Long-Acting Opioids in Long-Stay Nursing Home Residents.
Pimentel CB; Gurwitz JH; Tjia J; Hume AL; Lapane KL
J Am Geriatr Soc; 2016 Sep; 64(9):1772-8. PubMed ID: 27487158
[TBL] [Abstract][Full Text] [Related]
2. Long-acting opioid initiation in US nursing homes.
Hunnicutt JN; Hume AL; Ulbricht CM; Tjia J; Lapane KL
Pharmacoepidemiol Drug Saf; 2019 Jan; 28(1):31-38. PubMed ID: 29869441
[TBL] [Abstract][Full Text] [Related]
3. Changes in consumption of opioid analgesics in Israel 2009 to 2016: An update focusing on oxycodone and fentanyl formulations.
Ponizovsky AM; Marom E; Weizman A; Schwartzberg E
Pharmacoepidemiol Drug Saf; 2018 May; 27(5):535-540. PubMed ID: 29488288
[TBL] [Abstract][Full Text] [Related]
4. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
5. A comparison of oral controlled-release morphine and oxycodone with transdermal formulations of buprenorphine and fentanyl in the treatment of severe pain in cancer patients.
Nosek K; Leppert W; Nosek H; Wordliczek J; Onichimowski D
Drug Des Devel Ther; 2017; 11():2409-2419. PubMed ID: 28860712
[TBL] [Abstract][Full Text] [Related]
6. [Prescription of high-potency opioids in 2011].
Hoffmann F; Glaeske G; Windt R
Schmerz; 2012 Dec; 26(6):707-14. PubMed ID: 23183991
[TBL] [Abstract][Full Text] [Related]
7. Comparative out-of-hospital mortality of long-acting opioids prescribed for non-cancer pain: A retrospective cohort study.
Chung CP; Dupont WD; Murray KT; Hall K; Stein CM; Ray WA
Pharmacoepidemiol Drug Saf; 2019 Jan; 28(1):48-53. PubMed ID: 30003613
[TBL] [Abstract][Full Text] [Related]
8. Changes in trends and pattern of strong opioid prescribing in primary care.
Zin CS; Chen LC; Knaggs RD
Eur J Pain; 2014 Oct; 18(9):1343-51. PubMed ID: 24756859
[TBL] [Abstract][Full Text] [Related]
9. Frequency of long-acting opioid analgesic initiation in opioid-naïve nursing home residents.
Dosa DM; Dore DD; Mor V; Teno JM
J Pain Symptom Manage; 2009 Oct; 38(4):515-21. PubMed ID: 19375273
[TBL] [Abstract][Full Text] [Related]
10. Geographic Variation in the Initiation of Commonly Used Opioids and Dosage Strength in United States Nursing Homes.
Hunnicutt JN; Baek J; Alcusky M; Hume AL; Liu SH; Ulbricht CM; Tjia J; Lapane KL
Med Care; 2018 Oct; 56(10):847-854. PubMed ID: 30113423
[TBL] [Abstract][Full Text] [Related]
11. Therapy switching in patients receiving long-acting opioids.
Berger A; Hoffman DL; Goodman S; Delea TE; Seifeldin R; Oster G
Ann Pharmacother; 2004 Mar; 38(3):389-95. PubMed ID: 14742831
[TBL] [Abstract][Full Text] [Related]
12. Patterns of initial opioid prescription and its association with short-term and long-term use among opioid-naïve patients in Malaysia: a retrospective cohort study.
Zin CS; Nazar NI; Rahman NSA; Ahmad WR; Rani NS; Ng KS
BMJ Open; 2019 Jul; 9(7):e027203. PubMed ID: 31270113
[TBL] [Abstract][Full Text] [Related]
13. A comparison of daily average consumption (DACON) of oxycodone and oxymorphone long-acting oral tablets.
Rubino M; Summers KH; Puenpatom A; Fu C; Ohsfeldt RL; Ben-Joseph RH
J Manag Care Pharm; 2011 Jun; 17(5):367-76. PubMed ID: 21657806
[TBL] [Abstract][Full Text] [Related]
14. High-Dose Opioid Prescribing and Opioid-Related Hospitalization: A Population-Based Study.
Fernandes K; Martins D; Juurlink D; Mamdani M; Paterson JM; Spooner L; Singh S; Gomes T
PLoS One; 2016; 11(12):e0167479. PubMed ID: 27973601
[TBL] [Abstract][Full Text] [Related]
15. Twenty-five years of prescription opioid use in Australia: a whole-of-population analysis using pharmaceutical claims.
Karanges EA; Blanch B; Buckley NA; Pearson SA
Br J Clin Pharmacol; 2016 Jul; 82(1):255-67. PubMed ID: 26991673
[TBL] [Abstract][Full Text] [Related]
16. [Chronic non-cancer-related pain. Long-term treatment with rapid-release and short-acting opioids in the context of misuse and dependency].
Scharnagel R; Kaiser U; Schütze A; Heineck R; Gossrau G; Sabatowski R
Schmerz; 2013 Feb; 27(1):7-19. PubMed ID: 23340881
[TBL] [Abstract][Full Text] [Related]
17. Opioid switch in palliative care, opioid choice by clinical need and opioid availability.
Müller-Busch HC; Lindena G; Tietze K; Woskanjan S
Eur J Pain; 2005 Oct; 9(5):571-9. PubMed ID: 16139186
[TBL] [Abstract][Full Text] [Related]
18. Increases in controlled-release oxycodone utilisation following the subsidy of oxycodone with naloxone formulations: An Australian population-based study.
Schaffer AL; Karanges EA; Buckley NA; Wilson A; Degenhardt L; Larance B; Pearson SA
Pharmacoepidemiol Drug Saf; 2019 Jan; 28(1):97-105. PubMed ID: 30421838
[TBL] [Abstract][Full Text] [Related]
19. Commonly Initiated Opioids and Risk of Fracture Hospitalizations in United States Nursing Homes.
Hunnicutt JN; Hume AL; Liu SH; Ulbricht CM; Tjia J; Lapane KL
Drugs Aging; 2018 Oct; 35(10):925-936. PubMed ID: 30187291
[TBL] [Abstract][Full Text] [Related]
20. Prescription of Long-Acting Opioids and Mortality in Patients With Chronic Noncancer Pain.
Ray WA; Chung CP; Murray KT; Hall K; Stein CM
JAMA; 2016 Jun; 315(22):2415-23. PubMed ID: 27299617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
